Page 6 - Acrivon Therapeutics News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Acrivon Therapeutics (NASDAQ:ACRV) PT Lowered to $14 00 at LADENBURG THALM/SH SH

Acrivon Therapeutics (NASDAQ:ACRV) PT Lowered to $14 00 at LADENBURG THALM/SH SH
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

New yorkUnited statesCharles schwab investment management incYork mellon corpAcrivon therapeutics incCitigroup incWells fargo companyYork state common retirement fundAcrivon therapeuticsFree reportNew york mellon corpCharles schwab investment managementSchwab investment managementGet free reportAcrivon predictive precision proteomicsAcrivon therapeutics daily

Next-Gen PARP Inhibitor Shows Benefit in Breast Cancer Patients

Next-Gen PARP Inhibitor Shows Benefit in Breast Cancer Patients
miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.

United statesHong kongUnited kingdomHaihe biopharmaBiocity biopharmaCalithera biosciencesTerremoto biosciencesBridgene biosciencesEli lillyTimothya yapRadiopharm theranosticsArtios pharmaDaiichi sankyoInstitut gustave roussyAduro biotech incAtrin pharmaceuticals

Acrivon Therapeutics (ACRV) Outperform Rating Reiterated at BMO Capital Markets

Acrivon Therapeutics (ACRV) Outperform Rating Reiterated at BMO Capital Markets
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

New yorkUnited statesYork state common retirement fundWells fargo companyAcrivon therapeutics incAcrivon therapeutics company profileCharles schwab investment management incYork mellon corpCitigroup incAcrivon therapeuticsFree reportNew york mellon corpCharles schwab investment managementSchwab investment managementGet free reportAcrivon predictive precision proteomics

Acrivon Therapeutics (NASDAQ:ACRV) Earns Market Outperform Rating from JMP Securities

Acrivon Therapeutics (NASDAQ:ACRV) Earns Market Outperform Rating from JMP Securities
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

New yorkUnited statesBarclays plcYork state common retirement fundCitigroup incWells fargo companyAcrivon therapeutics incAcrivon therapeuticsFree reportState teachers retirement systemGet free reportAcrivon predictive precision proteomicsAcrivon therapeutics daily

Acrivon Therapeutics, Inc (NASDAQ:ACRV) Receives $22 14 Consensus Price Target from Analysts

Acrivon Therapeutics, Inc. (NASDAQ:ACRV – Get Free Report) has been given a consensus rating of “Buy” by the seven research firms that are presently covering the company, Marketbeat Ratings reports. Seven analysts have rated the stock with a buy recommendation. The average 1-year target price among analysts that have issued ratings on the stock in […]

United statesNew yorkAcrivon therapeutics incYork state common retirement fundWells fargo companyBarclays plcCitigroup incAcrivon therapeuticsGet free reportMarketbeat ratingsState teachers retirement systemGet freeAcrivon predictive precision proteomicsAcrivon therapeutics daily